Get research updatesPublic study records, presented in a clearer and more patient-friendly format for mental health research discovery.
Researchers compared SEP-363856 75mg, SEP-363856 100mg and placebo to find out how the approaches affected psychotic symptoms in people with schizophrenia.
This study has finished and is no longer accepting participants.
Multiple locations, including Rogers
A Clinical Trial to Assess the Efficacy of a Plant-based Energy Shot on Focus and ADHD-like Symptoms
This study has finished and is no longer accepting participants.
In Santa MonicaA Clinical Trial to Assess the Impact of an Alcohol Alternative Herbal Tincture on Signs of Stress Anxiety and Sleep Quality.
This study has finished and is no longer accepting participants.
In Santa MonicaResearchers are studying SEP-4199 CR, tracking side effects to assess long-term safety and tolerability in people with bipolarity type I during a depressive episode.
This study ended early.
Multiple locations, including HuntsvilleThis study evaluated the safety of JX11502MA for people with schizophrenia.
This study has finished and is no longer accepting participants.
In ShanghaiResearchers are comparing SEP-363856 50 mg, SEP-363856 75 mg and placebo to find out how the approaches affect psychotic symptoms in people with schizophrenia.
This study ended early.
Multiple locations, including BeijingResearchers are studying SEP-363856, tracking side effects to assess long-term safety and tolerability in people with schizophrenia.
This study ended early.
Multiple locations, including Konan-shiA Randomized, Parallel Group, Double Blind, Placebo Controlled, Clinical Trial of Augmentation With Atomoxetine for the Treatment of Negative Symptoms in Patients With Schizophrenia and Schizoaffective Disorder
This study has finished and is no longer accepting participants.
In PittsburghResearchers compared SEP-363856 50mg, SEP-363856 75mg and placebo to find out how the approaches affected psychotic symptoms in people with schizophrenia.
This study has finished and is no longer accepting participants.
Multiple locations, including Little RockInvestigating Factors Affecting Clinical Trial Participation Rates in Patients With Bipolar Disorder
Current recruitment status is unconfirmed.
In San Francisco
Care Technology to Ascertain, Treat, and Engage the Community to Heal Depression in Patients With Multiple Sclerosis: Closing the Gaps in Depression Care for People With MS By Closing the Information Loop
This study is no longer accepting new participants.
In San FranciscoA cluster randomised control trial of the impact of the ‘Breaking the Man Code’ workshops on adolescent boys’ intentions to seek help
This study has finished and is no longer accepting participants.
In AustraliaWe gather information about mental health clinical trials from the public registries we index. Coverage is still expanding, so some studies may not appear yet.